The IAEA has entered into strategic partnership agreements with three companies in the field of dosimetry and quality assurance as part of its efforts to enhance access to safe and effective radiation medicine for cancer care in low- and- middle income countries (LMICs). Signed under the umbrella of the IAEA’s Rays of Hope: Cancer Care for All initiative, the agreements with IBA Dosimetry, PTW-Freiburg Physikalisch-Technische Werkstätten Dr. Pychlau GmbH (PTW-Freiburg) and Standard Imaging will enhance access to calibration and dosimetry services and will strengthen training in quality assurance and dosimetry for LMICs.
“The partnerships with IBA Dosimetry, PTW-Freiburg and Standard Imaging present a promising opportunity to significantly enhance the quality and precision of radiation therapy treatments in LMICs that seek support through the IAEA’s Rays of Hope initiative, and will advance the objectives of the initiative,” said Hua Liu, Deputy Director General and Head of the IAEA’s Department of Technical Cooperation. “We are keen to start working with these companies to address the needs of the Member States that seek support under the initiative,” he added.
Accurate dosimetry, which measures exposure to ionizing radiation, is essential for the safe and effective use of nuclear technology, especially in the medical field. Contributions from the three partnerships include dosimetry and quality assurance tools, alongside substantial support through cost-free or significantly subsidized vendor-agnostic training. These will enhance the training and research capabilities of Rays of Hope Anchor Centres, benefitting hospitals and patients around the world.